MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Novo Nordisk and Eli Lilly are both raking in billions from their blockbuster weight loss drugs that are also approved to ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Below, I'll break down what's going on at Viking and explain how the company may emerge as a competitive force in the weight ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

MariTide, positioned as a monthly alternative to weekly injections offered by competitors Novo Nordisk NVO and Eli Lilly, ...

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...

In the subsequent 5 years to follow, Novo Nordisk’s newest products, presently in FDA trials, are targeting the obesity ...

Conditions are getting a bit more challenging for the drugmaker.